American Journal of Obstetrics & Gynecology
Volume 203, Issue 6 , Pages 561.e1-561.e5 , December 2010

Intramuscular 17α-hydroxyprogesterone caproate administration attenuates immunoresponsiveness of maternal peripheral blood mononuclear cells

Presented at the 29th Annual Meeting of the Society for Maternal-Fetal Medicine, San Diego, CA, Jan. 26-31, 2009.

  • Lisa M. Foglia, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Madigan Army Medical Center, Joint Base Lewis McChord, Tacoma, WA
    • Corresponding Author InformationReprints: Lisa M. Foglia, MD, FACOG, MCHJ-OG (ADC/3N), Fitzsimmons Dr., Tacoma, WA 98431
    • ,
  • Danielle L. Ippolito, PhD

      Affiliations

    • Department of Clinical Investigation, Madigan Army Medical Center, Joint Base Lewis McChord, Tacoma, WA
    • ,
  • Jonathan D. Stallings, PhD

      Affiliations

    • Department of Clinical Investigation, Madigan Army Medical Center, Joint Base Lewis McChord, Tacoma, WA
    • ,
  • Craig M. Zelig, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Madigan Army Medical Center, Joint Base Lewis McChord, Tacoma, WA
    • ,
  • Peter G. Napolitano, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Madigan Army Medical Center, Joint Base Lewis McChord, Tacoma, WA

Received 1 March 2010 ,Revised 17 May 2010 ,Accepted 15 July 2010.

References 

  1. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188:419–424
  2. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379–2385
  3. O'Brien JM, Adair CD, Lewis DF, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007;30:687–696
  4. American College of Obstetricians and Gynecologists. Use of progesterone to reduce preterm birth (ACOG committee opinion no. 419). Obstet Gynecol. 2008;112:963–965
  5. Sfakianaki AK, Norwitz ER. Mechanisms of progesterone action in inhibiting prematurity. J Maternal Fetal Neonatal Med. 2006;19:763–772
  6. Naccasha N, Gervasi MT, Chaiworapongsa T. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol. 2001;185:1118–1123
  7. Christianens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol. 2008;79:50–57
  8. Haney AF, Weinberg JB. Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate. Am J Obstet Gynecol. 1988;159:450–454
  9. Davies S, Dai D, Wolf DM, Leslie KK. Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells. J Soc Gynecol Investig. 2004;11:494–499
  10. Bouman A, Moes H, Heineman MJ, de Leij LFMH, Faas MM. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Fertil Steril. 2001;76:555–559
  11. Amory J, Lawler R, Shields L. Hydroxyprogesterone caproate and progesterone increase tumor necrosis-alpha production in lipopolysaccharide stimulated whole blood from non-pregnant women. J Perinat Med. 2005;33:506–509
  12. Yuan M, Jordan F, McInnes IB, Harnett MM, Norman JE. Leukocytes are primed in peripheral blood for activation during labor. Mol Hum Reprod. 2009;15:713–724
  13. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179:194–202
  14. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF, Petraglia F. Inflammation in pregnancy. Reprod Sci. 2009;16:206–215
  15. Le Bouar G, Lassel L, Poulain P. Markers on infection and inflammation in the amniotic fluid: therapeutic contribution of amniocentesis. J Gynecol Obstet Biol Reprod. 2002;31(Suppl 7):5S52-6
  16. Splichal I, Trebichavsky I. Cytokines and other important inflammatory mediators in gestation and bacterial intraamniotic infections. Folia Microbiol. 2001;46:345–351
  17. Romero R, Goncalves LF, Chaiworapongsa T, Kusanovic JP, Espinoza J. Mechanisms of preterm labor and preterm premature rupture of the membranes. In:  Kurjak A,  Chervenak FA editor. Textbook of perinatal medicine. 2nd ed.. London, UK: Informa UK Ltd; 2006;p. 1379–1393
  18. Schwartz N, Xue X, Elovitz MA, Dowling O, Metz CN. Progesterone suppresses the fetal inflammatory response ex vivo. Am J Obstet Gynecol. 2009;201:211.e1–211.e9
  19. Gotkin JL, Celver J, McNutt P, et al. Progesterone reduces LPS induced IL-6 secretion in fetoplacental chorionic arteries, fractionated cord blood and maternal mononuclear cells. Am J Obstet Gynecol. 2006;195:1015–1019
  20. Katial RK, Sachanandani D, Pinney C, Lieberman MM. Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Clin Diagn Lab Immunol. 1998;5:78–81
  21. Jones LA, Anthony JP, Henriquez FL, et al. Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology. 2008;125:59–69
  22. Stopinska-Gluszak U, Waligora J, Grzela T, et al. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol. 2006;69:65–75
  23. Bouman A, Schipper M, Heineman MJ, Faas M. 17-beta-estradiol and progesterone do not influence the production of cytokines from lipopolysaccharide-stimulated monocytes in humans. Fertil Steril. 2004;82(Suppl 3):1212–1219
  24. Duvigneau JC, Piskernik C, Haindl S, et al. A novel endotoxin-induced pathway: upregulation of heme oxygenase 1, accumulation of free iron, and free iron mediated mitochondrial dysfunction. Lab Invest. 2008;88:70–77
  25. Sadeghi K, Berger A, Langgartner M, et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis. 2007;195:296–302
  26. Kimbrell MR, Warshakoon H, Cromer JR, et al. Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. Immunol Lett. 2008;118:132–141
  27. Wang JE, Jorgensen PF, Almlof M, et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun. 2000;3965–3970
  28. Mattsson E, Hartung T, Morath S, Egesten A. Highly purified lipoteichoic acid from Staphylococcus aureus induces procoagulant activity and tissue factor expression in human monocytes but is a weak inducer in whole blood: comparison with peptidoglycan. Infect Immun. 2004;4322–4326

 The views expressed herein are those of the authors and do not reflect the official policy of the Department of the Army, the Department of Defense, or the US Government.

 Cite this article as: Foglia LM, Ippolito DL, Stallings JD, et al. Intramuscular 17α-hydroxyprogesterone caproate administration attenuates immunoresponsiveness of maternal peripheral blood mononuclear cells. Am J Obstet Gynecol 2010;203:561.e1-5.

PII: S0002-9378(10)00900-2

doi: 10.1016/j.ajog.2010.07.016

American Journal of Obstetrics & Gynecology
Volume 203, Issue 6 , Pages 561.e1-561.e5 , December 2010

Article Tools

* Image Usage & Resolution